AA
ABBV icon

Aufman Associates’s AbbVie ABBV Stock Holding History

Aufman Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$804K Sell
3,196
-66
-2% -$14.2K 0.32% 26
2026
Q1 		$709K Hold
3,262
– – 0.35% 26
2025
Q4 		$745K Hold
3,262
– – 0.38% 25
2025
Q3 		$755K Hold
3,262
– – 0.43% 25
2025
Q2 		$605K Buy
3,262
+1
+0% +$186 0.37% 27
2025
Q1 		$683K Sell
3,261
-70
-2% -$13.6K 0.47% 23
2024
Q4 		$592K Hold
3,331
– – 0.4% 24
2024
Q3 		$658K Buy
3,331
+870
+35% +$162K 0.42% 23
2024
Q2 		$422K Hold
2,461
– – 0.3% 25
2024
Q1 		$448K Hold
2,461
– – 0.32% 25
2023
Q4 		$381K Buy
2,461
+1
+0% +$146 0.29% 26
2023
Q3 		$367K Sell
2,460
-55
-2% -$8.07K 0.31% 27
2023
Q2 		$339K Sell
2,515
-153
-6% -$22.4K 0.28% 28
2023
Q1 		$425K Sell
2,668
-67
-2% -$10.2K 0.36% 25
2022
Q4 		$442K Sell
2,735
-20
-0.7% -$3.07K 0.41% 21
2022
Q3 		$370K Sell
2,755
-149
-5% -$21.4K 0.39% 24
2022
Q2 		$445K Sell
2,904
-225
-7% -$34.4K 0.42% 22
2022
Q1 		$507K Sell
3,129
-110
-3% -$16K 0.4% 22
2021
Q4 		$439K Buy
3,239
+21
+0.7% +$2.48K 0.32% 26
2021
Q3 		$347K Hold
3,218
– – 0.29% 26
2021
Q2 		$362K Buy
3,218
+118
+4% +$13.3K 0.28% 26
2021
Q1 		$335K Hold
3,100
– – 0.28% 26
2020
Q4 		$332K Hold
3,100
– – 0.3% 26
2020
Q3 		$272K Sell
3,100
-103
-3% -$9.7K 0.29% 29
2020
Q2 		$314K Hold
3,203
– – 0.36% 26
2020
Q1 		$244K Hold
3,203
– – 0.34% 33
2019
Q4 		$284K Buy
+3,203
New +$266K 0.29% 33

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aufman Associates's ABBV Position: Q2 2026 in Review

Aufman Associates reduced its AbbVie (ABBV) stake by 2% in Q2 2026, selling an estimated $14.2K and leaving 3,196 shares worth $804K. The position accounts for 0.32% of the portfolio, ranked #26.

Aufman Associates first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aufman Associates held 3,196 shares of AbbVie worth $804K as of Q2 2026.
  • Aufman Associates sold 66 AbbVie shares in Q2 2026, an estimated $14.2K.
  • AbbVie made up 0.32% of Aufman Associates's portfolio in Q2 2026, its #26 holding.
  • Aufman Associates first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aufman Associates's 13F filing for Q2 2026, filed 12 Aug 2026.